RxDoctor Payments Data

Shani McGinnis, DPM

Podiatrist · Spokane Valley, WANPI 1003809252

Payments from drug & device makers

What this record shows

Stryker accounts for 87.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,870 and has fallen 99.1% since, to $16 in 2025.

$2,500in general payments, 2019–2025

Across 18 payments — averaging $138.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Amgen$84
  • AbbVie$82
  • Smith+Nephew$65
  • Skeletal Dynamics Inc$31
  • Paragon 28, Inc.$27
  • plus $16 from 1 others

What the payments were for

  • Travel & lodging$1,35354%
  • Food & beverage$1,14746%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)12$2,195
Amgen1$84
AbbVie1$82
Smith+Nephew1$65
Skeletal Dynamics Inc1$31
Paragon 28, Inc.1$27
Fusion Orthopedics USA, LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,500 in reported general payments places this provider in the 70th percentile of 134 podiatrist providers in Washington.

See all podiatrist providers in Washington

Medicare billing

Part B allowed, 2024
$82,335
Medicare patients
265
Services billed
982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Colchicine27$2,689
Gabapentin57$1,150
Doxycycline Hyclate57$634
Terbinafine Hcl120$545
Pregabalin17$483
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$431
Allopurinol19$357
Ciclopirox11$320
Fluconazole21$304
Oxycodone Hcl28$250
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$146
Meloxicam13$30

Paid to pharmacies, not to this prescriber.

Other podiatrist in Spokane Valley

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →